Roche’s giant deal with Philly-based Spark is delayed by FTC queries

This represents at least the fourth delay for the much-ballyhooed deal, considered a landmark event for gene therapy research in Philadelphia.

Roche’s giant deal with Philly-based Spark is delayed by FTC queries

This represents at least the fourth delay for the much-ballyhooed deal, considered a landmark event for gene therapy research in Philadelphia.

HUGE cannabis startup, FSD Pharma, takes deep root in Philadelphia

The company’s aspirations are neatly summed up in its proposed stock ticker symbol: HUGE.

HUGE cannabis startup, FSD Pharma, takes deep root in Philadelphia

The company’s aspirations are neatly summed up in its proposed stock ticker symbol: HUGE.

Puerto Rico, eager to keep its pharma industry, targets drug, device makers at BIO 2019 in Philly

It’s not just about luring employers from the mainland to his island. Puerto Rico wants to make sure the companies there continue investing and expanding.”

Puerto Rico, eager to keep its pharma industry, targets drug, device makers at BIO 2019 in Philly

It’s not just about luring employers from the mainland to his island. Puerto Rico wants to make sure the companies there continue investing and expanding.”
More Stories

Philly’s biotech leaders pitched the city at Bio 2019 to CEOs and some even seemed impressed

"This is a sales pitch. We want you here in Philadelphia,” said Daniel Hilferty, CEO of Independence Blue Cross, the region’s largest health insurer.

Exton firm raises US $200 million in Hong Kong IPO

The sale raised HK $1.51 billion, or nearly $200 million in U.S. dollars.

Big marijuana firms are ‘rolling up’ local dispensaries and growers, skirting Pennsylvania’s laws

One company controls more licenses than the law allows any one company to control. Experts say there is a buying frenzy going on despite the legislature’s intent to encourage local ownership.

N.J. medical marijuana program set for major expansion after full legalization effort failed

New Jersey’s medical marijuana program is poised to explode in its size and scope if Gov. Murphy, whose efforts to legalize recreational use was stymied by political infighting, gets his way.

Column

DuPont’s $10M+ ad campaign: ‘Invent a Better N:ow’

NASA astronaut Cady Coleman will be among the spokespeople featured in the DuPont videos, which portray highlights of the company’s long list of products.

FDA holds hearings to determine legality of CBD in foods

“There is mass confusion in the marketplace,” said Peter Matz of the Food Marketing Institute.

New Jersey drug maker to pay $7 million to settle claims of inflating drug prices

In addition, Heritage was charged Thursday with a felony criminal count by the federal government for participating in a criminal antitrust conspiracy.

Two medical device makers in Wayne get big boosts

Washington, D.C.-based Vensana Capital this week led a $37 million investment in one Wayne firm and $25 million in another.

Why 20,000 biotech fans from all over the world will flock to Philly next week

Philadelphia, which is developing its reputation as a hotbed of biotechnology research and development, is hosting the world’s largest biotech industry event - the BIO International Convention.

Amicus Therapeutics signs $50 million pact to expand collaboration with Penn’s Gene Therapy Program

The five-year agreement will serve to develop new cures for lysosomal disorders and other rare diseases.

High drug costs lead 5 percent of seniors to skip or ration medication, study finds

About 5 percent of adults over age 65 said they skipped or rationed medication, or didn't fill a prescription because of cost, according to a new report.

Bala Cynwyd biotech raises $25.8 million for rare mitochondrial therapy, hoping to be the sector’s next shooting star

Chondrial is targeting Freidreich’s Ataxia (FA), a genetic disorder that affects one in 50,000 people in the United States.

Merck to acquire Dallas-based biotech Peloton Therapeutics in $2.2 billion deal

Peloton is a clinical-stage biopharmaceutical company focused on experimental cancer drugs.

SPECIAL REPORTS
Investigative reports, featured series, and guides to living in the Philadelphia region, brought to you by The Inquirer.
WHAT ARE YOU CURIOUS ABOUT?
Send us your burning questions, or vote on other readers' questions that pique your interest. Our journalists will work to answer them.